Home
>
National Drug Code (NDC)
>
Vitrasert
Vitrasert - 24208-412-01 - (Ganciclovir)
Drug Information of Vitrasert
| Product NDC: | 24208-412 |
| Proprietary Name: | Vitrasert |
| Non Proprietary Name: | Ganciclovir |
| Active Ingredient(s): | 4.5 mg/1 & nbsp; Ganciclovir |
| Administration Route(s): | INTRAVITREAL |
| Dosage Form(s): | IMPLANT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Vitrasert
| Product NDC: | 24208-412 |
| Labeler Name: | Bausch & Lomb Incorporated |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020569 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19960304 |
Package Information of Vitrasert
| Package NDC: | 24208-412-01 |
| Package Description: | 1 POUCH in 1 CARTON (24208-412-01) > 1 IMPLANT in 1 POUCH |
NDC Information of Vitrasert
| NDC Code | 24208-412-01 |
| Proprietary Name | Vitrasert |
| Package Description | 1 POUCH in 1 CARTON (24208-412-01) > 1 IMPLANT in 1 POUCH |
| Product NDC | 24208-412 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ganciclovir |
| Dosage Form Name | IMPLANT |
| Route Name | INTRAVITREAL |
| Start Marketing Date | 19960304 |
| Marketing Category Name | NDA |
| Labeler Name | Bausch & Lomb Incorporated |
| Substance Name | GANCICLOVIR |
| Strength Number | 4.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
